(Información remitida por la empresa firmante)
HUDDINGE, Sweden, Nov. 10, 2023 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced that Johan Liwing, CEO, will present the company at the at Investival Showcase Meeting in London, on November 13th
The LSX Investival Showcase meeting is one of Europe's biggest pitch events for early and growth stage companies.
